Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use Phase
Clinical trial NCT06913634 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06913634
- Sponsor
- Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-30
- Primary completion
- 2025-05-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.